Search Results - "Currow, David C"

Refine Results
  1. 1

    Health-related quality of life measured using the EQ-5D-5L: South Australian population norms by McCaffrey, Nikki, Kaambwa, Billingsley, Currow, David C, Ratcliffe, Julie

    Published in Health and quality of life outcomes (20-09-2016)
    “…Although a five level version of the widely-used EuroQol 5 dimensions (EQ-5D) instrument has been developed, population norms are not yet available for…”
    Get full text
    Journal Article
  2. 2

    Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness by Johnson, Miriam J, Yorke, Janelle, Hansen-Flaschen, John, Lansing, Robert, Ekström, Magnus, Similowski, Thomas, Currow, David C

    Published in The European respiratory journal (01-05-2017)
    “…Breathlessness that persists despite treatment for the underlying conditions is debilitating. Identifying this discrete entity as a clinical syndrome should…”
    Get full text
    Journal Article
  3. 3

    Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials by Temel, Jennifer S, Dr, Abernethy, Amy P, Prof, Currow, David C, Prof, Friend, John, MD, Duus, Elizabeth M, PhD, Yan, Ying, PhD, Fearon, Kenneth C, Prof

    Published in The lancet oncology (01-04-2016)
    “…Summary Background Patients with advanced cancer frequently experience anorexia and cachexia, which are associated with reduced food intake, altered body…”
    Get full text
    Journal Article
  4. 4

    Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review by Ekström, Magnus, Nilsson, Fredrik, Abernethy, Amy A, Currow, David C

    Published in Annals of the American Thoracic Society (01-07-2015)
    “…Patients with chronic obstructive pulmonary disease (COPD) commonly suffer from breathlessness, deconditioning, and reduced health-related quality of life…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer by Currow, David C., Glare, Paul, Louw, Sandra, Martin, Peter, Clark, Katherine, Fazekas, Belinda, Agar, Meera R.

    Published in Scientific reports (28-01-2021)
    “…This multi-site, double blind, parallel arm, fixed dose, randomised placebo controlled phase III study compared megestrol acetate 480 mg/day with dexamethasone…”
    Get full text
    Journal Article
  8. 8

    What Aspects of Quality of Life Are Important from Palliative Care Patients’ Perspectives? A Systematic Review of Qualitative Research by McCaffrey, Nicola, PhD, Bradley, Sandra, PhD, Ratcliffe, Julie, PhD, Currow, David C., BMed

    Published in Journal of pain and symptom management (01-08-2016)
    “…Abstract Context Despite the availability of numerous tools professing to measure quality of life (QOL) in the palliative care setting, no single instrument…”
    Get full text
    Journal Article
  9. 9

    Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness by Ekström, Magnus, Johnson, Miriam J, Huang, Chao, Currow, David C

    Published in The European respiratory journal (01-08-2020)
    “…Chronic breathlessness has devastating consequences. The minimal clinically important difference (MCID) for current intensity has been estimated as 9 mm on a…”
    Get full text
    Journal Article
  10. 10

    Management of Dyspnea in Advanced Cancer: ASCO Guideline by Hui, David, Bohlke, Kari, Bao, Ting, Campbell, Toby C, Coyne, Patrick J, Currow, David C, Gupta, Arjun, Leiser, Aliza L, Mori, Masanori, Nava, Stefano, Reinke, Lynn F, Roeland, Eric J, Seigel, Carole, Walsh, Declan, Campbell, Margaret L

    Published in Journal of clinical oncology (20-04-2021)
    “…To provide guidance on the clinical management of dyspnea in adult patients with advanced cancer. ASCO convened an Expert Panel to review the evidence and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Managing the supportive care needs of those affected by COVID-19 by Bajwah, Sabrina, Wilcock, Andrew, Towers, Richard, Costantini, Massimo, Bausewein, Claudia, Simon, Steffen T, Bendstrup, Elisabeth, Prentice, Wendy, Johnson, Miriam J, Currow, David C, Kreuter, Michael, Wells, Athol U, Birring, Surinder S, Edmonds, Polly, Higginson, Irene J

    Published in The European respiratory journal (01-04-2020)
    “…Globally, the number of people affected by coronavirus disease 2019 (COVID-19) is rapidly increasing. In most (>80%), the illness is relatively mild and can be…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    The PCOC Symptom Assessment Scale (SAS): A valid measure for daily use at point of care and in palliative care programs by Daveson, Barbara A, Allingham, Samuel Frederic, Clapham, Sabina, Johnson, Claire E, Currow, David C, Yates, Patsy, Eagar, Kathy

    Published in PloS one (25-03-2021)
    “…Very few measures are used successfully as part of routine care within national palliative care outcome programs. Only a handful of studies examine these…”
    Get full text
    Journal Article
  17. 17

    Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Toxicity of Subcutaneous Ketamine in the Management of Cancer Pain by HARDY, Janet, QUINN, Stephen, FAZEKAS, Belinda, PLUMMER, John, ECKERMANN, Simon, AGAR, Meera, SPRUYT, Odette, ROWETT, Debra, CURROW, David C

    Published in Journal of clinical oncology (10-10-2012)
    “…The anesthetic ketamine is widely used for pain related to cancer, but the evidence to support its use in this setting is weak. This study aimed to determine…”
    Get full text
    Journal Article
  18. 18

    Clinically Important Differences in the Intensity of Chronic Refractory Breathlessness by Johnson, Miriam J., MD, FRCP, MBChB (Hons), Bland, J. Martin, PhD, Oxberry, Stephen G., PhD, MRCP, MBChB, BSc (Hons), Abernethy, Amy P., MD, Currow, David C., FRACP

    Published in Journal of pain and symptom management (01-12-2013)
    “…Abstract Context Clinically important differences in chronic refractory breathlessness are ill defined but important in clinical practice and trial design…”
    Get full text
    Journal Article
  19. 19

    Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study by Bajwah, Sabrina, Davies, Joanna M, Tanash, Hanan, Currow, David C, Oluyase, Adejoke O, Ekström, Magnus

    Published in The European respiratory journal (01-12-2018)
    “…Safety concerns are a barrier to prescribing benzodiazepines (BDZs) and opioids in interstitial lung disease (ILD). We therefore examined the association of…”
    Get full text
    Journal Article
  20. 20

    BREATHLEssness in INDIA (BREATHE-INDIA)–Study protocol for the co-design of a community breathlessness intervention in India using realist methods and intervention mapping by Clark, Joseph, Salins, Naveen, Pearson, Mark, Spathis, Anna, Currow, David C, Williams, Siân, Johnson, Miriam

    Published in PloS one (02-11-2023)
    “…Background Breathlessness that persists despite treatment of causal disease(s) is disabling, associated with high therapy-related costs and poor socioeconomic…”
    Get full text
    Journal Article